Bianhong H. Wang

28 Fuxing Road
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Real-world efficacy and safety of golidocitinib in 3 patients with relapsed/refractory peripheral T-cell lymphoma.

Real-world efficacy and safety of golidocitinib in 3 patients with relapsed/refractory peripheral T-cell lymphoma.

Journal: Frontiers in oncology

Published: May 26, 2026

Myelopathy following intrathecal chemotherapy in a patient with acute lymphoblastic leukemia: a case report.

Myelopathy following intrathecal chemotherapy in a patient with acute lymphoblastic leukemia: a case report.

Journal: Frontiers in oncology

Published: April 10, 2026

The value of speckle tracking echocardiography in early identification of subclinical cardiac involvement in patients with multiple myeloma: a pilot retrospective study.

The value of speckle tracking echocardiography in early identification of subclinical cardiac involvement in patients with multiple myeloma: a pilot retrospective study.

Journal: Frontiers in medicine

Published: April 05, 2026

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report.

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report.

Journal: Frontiers in medicine

Published: March 26, 2026

Acquired dysfibrinogenemia with discordant fibrinogen assays preceding the diagnosis of λ light-chain multiple myeloma: a case report.

Acquired dysfibrinogenemia with discordant fibrinogen assays preceding the diagnosis of λ light-chain multiple myeloma: a case report.

Journal: Thrombosis journal

Published: January 09, 2026

Construction of a prognostic hierarchical model of intermediate-risk acute myeloid leukemia based on machine learning.

Construction of a prognostic hierarchical model of intermediate-risk acute myeloid leukemia based on machine learning.

Journal: Digital health

Published: June 17, 2025

Case Report: Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma.

Case Report: Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma.

Journal: Frontiers in immunology

Published: November 14, 2024

Clinical and pathological evaluation of cladribine treatment response in a case series of patients with xanthoma disseminatum.

Clinical and pathological evaluation of cladribine treatment response in a case series of patients with xanthoma disseminatum.

Journal: European journal of dermatology : EJD

Published: August 18, 2023

Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study.

Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study.

Journal: Annals of hematology

Published: December 30, 2022

Cladribine for the treatment with five male cases with xanthoma disseminatum

Cladribine for the treatment with five male cases with xanthoma disseminatum

Journal: Zhonghua nei ke za zhi

Published: August 03, 2022

Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.

Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome.

Journal: Frontiers in immunology

Published: March 11, 2022

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.

Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: May 11, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026